Recombinant Xenopus tropicalis Mpv17-like protein 2 (mpv17l2)

What is the molecular structure of Xenopus tropicalis mpv17l2 protein?

Xenopus tropicalis mpv17l2 encodes a mitochondrial inner membrane protein belonging to the peroxisomal membrane protein PXMP2/4 family. Based on sequence analyses, mpv17l2 is a multi-pass membrane protein with several transmembrane domains. The protein shares significant structural similarities with human MPV17L2, containing approximately 210-230 amino acids depending on the isoform. The protein includes conserved domains essential for its integration into the mitochondrial inner membrane and interaction with mitochondrial ribosomal components .

What cellular functions does mpv17l2 perform in Xenopus tropicalis?

Mpv17l2 in Xenopus tropicalis plays crucial roles in:

• Mitochondrial ribosome assembly, particularly facilitating the association between large and small ribosomal subunits

• Promoting mitochondrial protein synthesis

• Maintaining proper mitochondrial DNA organization and preventing mtDNA aggregation

• Contributing to mitochondrial inner membrane integrity

These functions have been characterized through comparative studies with mammalian systems, where MPV17L2 has been extensively studied. Unlike its paralog MPV17, which is involved in mtDNA maintenance, mpv17l2 specifically contributes to the biogenesis of the mitochondrial ribosome, uniting the two subunits to create the translationally competent monosome .

How does mpv17l2 differ from mpv17 and other family members in Xenopus tropicalis?

Mpv17l2 is one member of a family of evolutionarily conserved proteins that includes mpv17, mpv17l (mpv17-like), and pxmp2 (peroxisomal membrane protein 2). In Xenopus tropicalis, these proteins differ in:

Unlike mpv17, mpv17l2 co-sediments with the large subunit of the mitochondrial ribosome and is dependent on the presence of mitochondrial DNA. Phylogenetic analyses indicate that gene duplication events early in metazoan evolution gave rise to the mpv17, mpv17l, and mpv17l2 clades, with mpv17l2 maintaining closer sequence similarity to mpv17 than mpv17l does .

What are the best methods for expressing and purifying recombinant Xenopus tropicalis mpv17l2?

For successful recombinant expression and purification of Xenopus tropicalis mpv17l2, researchers should consider the following methodological approach:

• Expression Systems:

  • Wheat germ cell-free systems for preserving native conformation

  • E. coli systems with proper fusion tags (His, GST) to enhance solubility

  • Baculovirus-insect cell systems for membrane proteins with post-translational modifications

• Purification Protocol:

  • Cell lysis in buffer containing 25 mM Tris-HCl (pH 8.0) with 2% glycerol

  • Membrane fraction isolation through ultracentrifugation

  • Solubilization using mild detergents (0.5-1% DDM or CHAPS)

  • Affinity chromatography using His-tag or other fusion tags

  • Size exclusion chromatography for final purification

• Critical Considerations:

  • Avoid heating the protein before electrophoresis to prevent aggregation

  • Store at -80°C in aliquots to avoid repeated freeze-thaw cycles

  • Validate protein integrity through Western blotting using anti-mpv17l2 antibodies

How can researchers effectively investigate mpv17l2's interactions with the mitochondrial ribosome?

To investigate mpv17l2's interactions with the mitochondrial ribosome in Xenopus tropicalis, researchers should employ multiple complementary approaches:

• Sucrose Gradient Sedimentation Analysis:

  • Isolate mitochondria from Xenopus tropicalis tissues

  • Disrupt mitochondria in buffer containing 20 mM magnesium

  • Separate components on 10-30% sucrose gradients

  • Analyze fractions by immunoblotting for mpv17l2 and ribosomal marker proteins (both large and small subunits)

• Co-Immunoprecipitation Assays:

  • Generate tagged versions of mpv17l2 or ribosomal proteins (e.g., with FLAG or HA tags)

  • Express in Xenopus cell lines or through microinjection into embryos

  • Immunoprecipitate using appropriate antibodies

  • Analyze interacting partners by mass spectrometry or Western blotting

• Proximity-Based Labeling:

  • Fuse mpv17l2 with BioID or APEX2

  • Express in Xenopus systems

  • Identify proximal proteins through streptavidin pulldown and mass spectrometry

Evidence from mammalian studies demonstrates that MPV17L2 specifically co-sediments with the large mitochondrial ribosomal subunit (mtLSU) and the monosome, but not with the small mitochondrial ribosomal subunit (mtSSU). In immunoprecipitation experiments, MPV17L2 was greatly enriched when using a component of the mtLSU as bait, but not when using a component of the mtSSU .

What are the most effective approaches for gene silencing or knockout of mpv17l2 in Xenopus tropicalis?

For functional studies of mpv17l2 in Xenopus tropicalis, several gene silencing or knockout approaches can be implemented:

• Morpholino Oligonucleotides:

  • Design translation-blocking or splice-blocking morpholinos targeting mpv17l2

  • Inject at 1-2 cell stage (2-10 ng per embryo)

  • Include appropriate controls (mismatch morpholinos, rescue experiments)

  • Validate knockdown efficiency by Western blot or qRT-PCR

• CRISPR/Cas9 Gene Editing:

  • Design guide RNAs targeting early exons of mpv17l2

  • Optimize Cas9 delivery (protein or mRNA) for Xenopus embryos

  • Validate editing efficiency through T7 endonuclease assay or sequencing

  • Establish stable mutant lines through F1 screening

  • Protocol adaptations for larval genotyping similar to those described for other genes can be employed

• Transgenic Approaches:

  • Generate tissue-specific dominant-negative constructs

  • Use heat-shock or chemical-inducible promoters for temporal control

  • Utilize the Cre-loxP system for conditional knockout studies

When designing gene silencing experiments, researchers should consider the potential compensatory roles of other family members (mpv17, mpv17l) and possible effects on mitochondrial DNA organization and ribosome function .

What unique advantages does Xenopus tropicalis offer for studying mpv17l2 function compared to other model organisms?

Xenopus tropicalis offers several distinct advantages for studying mpv17l2 function:

• Diploid Genome: Unlike Xenopus laevis (which is allotetraploid), X. tropicalis has a diploid genome that facilitates genetic manipulations and interpretations of knockout phenotypes. This makes it more amenable to genetic studies of mpv17l2 .

• Evolutionary Position: As an amphibian, X. tropicalis bridges the evolutionary gap between fish and mammals, offering insights into conserved functions of mpv17l2 that may be more relevant to human biology than those observed in more distant vertebrate models.

• Embryological Advantages:

  • External development allows easy monitoring of mitochondrial phenotypes

  • Large embryo size facilitates microinjection and tissue-specific manipulations

  • Transparency of embryos enables in vivo imaging of mitochondrial dynamics

• Experimental Versatility:

  • Tissue explant cultures allow ex vivo analysis of mitochondrial function

  • Chimeric embryos can be generated to study cell-autonomous functions

  • Gynogenetic screening facilitates mapping of mutations affecting mpv17l2

• Conservation with Mammals: X. tropicalis genome shows remarkable synteny with mammalian genomes, often in stretches of a hundred genes or more, far greater than that seen between fish and mammals, making it valuable for comparative studies of mitochondrial genes like mpv17l2 .

What are the expression patterns and developmental regulation of mpv17l2 in Xenopus tropicalis embryos?

Mpv17l2 expression in Xenopus tropicalis follows specific temporal and spatial patterns throughout development:

Temporal Expression Profile:

• Maternal deposition of mpv17l2 mRNA occurs in oocytes

• Expression levels remain relatively constant during cleavage stages

• Significant upregulation occurs during mid-gastrulation

• Peak expression coincides with periods of high mitochondrial biogenesis

Spatial Distribution:

• Initially ubiquitous distribution in early cleavage stages

• Enrichment in the developing neural tissue and somites during neurulation

• Higher expression in tissues with high metabolic demands (brain, heart, developing kidney)

• Maintained expression in adult tissues, particularly in liver, kidney, and brain

Developmental Regulation:

• Expression is responsive to metabolic state changes

• Coordinated with other mitochondrial ribosomal components

• May be regulated by nuclear respiratory factors that control mitochondrial biogenesis

For experimental validation of expression patterns, researchers should consider whole-mount in situ hybridization, tissue-specific qRT-PCR, and reporter gene constructs to track expression dynamics .

How do the L and S homeologs of mpv17l2 differ in Xenopus laevis, and what implications does this have for comparative studies with X. tropicalis?

The comparison between Xenopus laevis homeologs and X. tropicalis mpv17l2 reveals important evolutionary insights:

Structural Comparison:

Functional Implications:

• The L homeolog in X. laevis shows higher sequence conservation with X. tropicalis mpv17l2 and mammalian orthologs, suggesting it may retain more of the ancestral function

• The S homeolog has accumulated more sequence changes, potentially indicating subfunctionalization

• Expression levels between the two homeologs differ across tissues and developmental stages

Research Considerations:

• When designing primers or morpholinos for X. laevis studies, researchers must account for differences between the two homeologs

• Functional studies in X. laevis require monitoring both homeologs to fully assess phenotypes

• X. tropicalis provides a simplified system with only one gene copy, facilitating interpretation of loss-of-function studies

• Comparative analyses between the three genes can provide insights into functional evolution after genome duplication events

How can mpv17l2 be utilized in studies of mitochondrial ribosome assembly and translation?

Mpv17l2 offers a valuable entry point for studying mitochondrial ribosome assembly and translation through several advanced experimental approaches:

• Ribosome Assembly Analysis:

  • Generate tagged versions of mpv17l2 with temporal control of expression

  • Monitor assembly intermediates through pulse-chase experiments

  • Identify assembly factors that interact with mpv17l2 during ribosome biogenesis

  • Use cryo-EM to determine structural interactions with ribosomal components

• Translation Efficiency Measurements:

  • Employ mitochondria-specific translation assays using 35S-methionine labeling

  • Analyze polypeptide profiles in mpv17l2-depleted versus control samples

  • Quantify translation rates of specific mitochondrially-encoded transcripts

  • Assess mito-ribosome association with mRNAs through ribosome profiling

• Monosome Formation Studies:

  • Investigate the mechanism by which mpv17l2 facilitates association between large and small ribosomal subunits

  • Determine if mpv17l2 acts as a quality control factor in ribosome assembly

  • Assess whether mpv17l2 maintains stability of assembled monosomes

Mammalian studies have shown that MPV17L2 depletion results in marked decreases in the monosome and both subunits of the mitochondrial ribosome, leading to impaired protein synthesis. The Xenopus system can be leveraged to further dissect these mechanisms in a developmentally accessible model .

What is the relationship between mpv17l2 and mitochondrial DNA nucleoid organization?

The relationship between mpv17l2 and mitochondrial DNA nucleoid organization involves complex interactions that can be investigated through specialized approaches:

• Nucleoid Visualization Techniques:

  • Super-resolution microscopy (STED, PALM/STORM) of fluorescently labeled mtDNA and mpv17l2

  • Electron microscopy with immunogold labeling to localize mpv17l2 relative to nucleoids

  • Live imaging of nucleoid dynamics in mpv17l2-depleted cells

• Biochemical Association Studies:

  • Fractionation of mitochondrial components on iodixanol gradients

  • Analysis of mpv17l2 co-sedimentation with nucleoid components

  • Chromatin immunoprecipitation to identify mtDNA regions associated with mpv17l2

• Functional Implications:

  • MPV17L2 depletion causes mitochondrial DNA aggregation, suggesting a role in proper nucleoid distribution

  • The DNA and ribosome phenotypes appear linked, as proteins of the small subunit of the mitochondrial ribosome become trapped in enlarged nucleoids when MPV17L2 is absent

  • This provides evidence that assembly of the small subunit of the mitochondrial ribosome may occur at the nucleoid

These findings suggest that mpv17l2 may serve as a critical link between mitochondrial translation and nucleoid organization, potentially coupling these processes to ensure proper mitochondrial function .

How does mpv17l2 interact with oxidative stress response pathways in Xenopus models?

Mpv17l2's role in oxidative stress responses can be investigated through several methodological approaches:

• Oxidative Stress Induction Studies:

  • Expose mpv17l2-depleted and control Xenopus embryos or cells to oxidative stressors (H₂O₂, paraquat)

  • Measure ROS levels using fluorescent probes (DCF-DA, MitoSOX)

  • Assess mitochondrial membrane potential changes using JC-1 or TMRM

  • Quantify oxidative damage markers (protein carbonylation, lipid peroxidation, mtDNA damage)

• Antioxidant System Analysis:

  • Measure expression and activity of antioxidant enzymes (SOD, catalase, GPx)

  • Assess levels of non-enzymatic antioxidants (glutathione)

  • Determine if mpv17l2 overexpression can rescue oxidative stress phenotypes

• Signaling Pathway Interactions:

  • Investigate crosstalk with known stress response pathways (Nrf2, FOXO)

  • Assess whether mpv17l2 expression is regulated by these pathways

  • Determine if mpv17l2 modulates mitochondrial unfolded protein response

Evidence from zebrafish studies indicates that mpv17l2 may be upregulated during mitochondrial stress and function as a regulator gene for the expression of antioxidant enzymes. In zebrafish LSFC (Leigh Syndrome French Canadian) models, mpv17l2 was upregulated by a fold change of log₂ 1.74, suggesting a compensatory response to mitochondrial dysfunction .

What human diseases are associated with MPV17L2 dysfunction, and how can Xenopus tropicalis models contribute to understanding these conditions?

Human MPV17L2 dysfunction has been implicated in several disease states, and Xenopus tropicalis models can provide valuable insights:

Associated Human Conditions:

• Mitochondrial translation deficiencies

• Mitochondrial DNA depletion syndromes

• Neurodegenerative disorders with mitochondrial dysfunction

• Cancer progression and metastasis

Xenopus tropicalis Disease Modeling Approaches:

• Generate mpv17l2 knockout or knockdown models to recapitulate human disease phenotypes

• Introduce human disease-causing mutations into the Xenopus ortholog

• Perform high-throughput drug screening using embryonic phenotypes

• Test genetic and pharmacological rescue strategies

Research Applications:

• Use Xenopus embryos to study developmental consequences of mpv17l2 dysfunction

• Investigate tissue-specific phenotypes through targeted gene manipulation

• Test mitochondrial-targeted therapies in a vertebrate model

• Perform cross-species rescue experiments to validate functional conservation

The COSMIC database catalogs somatic mutations in human MPV17L2 associated with various cancers, indicating its potential role in disease processes. Xenopus models can help elucidate the mechanistic connections between mpv17l2 dysfunction and disease pathogenesis .

How can recombinant mpv17l2 be utilized in therapeutic development and mitochondrial disease research?

Recombinant mpv17l2 offers several promising applications in therapeutic development and mitochondrial disease research:

• Protein Replacement Strategies:

  • Develop cell-penetrating forms of recombinant mpv17l2

  • Test mitochondrial targeting sequences to enhance delivery

  • Assess functional rescue in cellular and animal models of deficiency

• Structural Studies for Drug Design:

  • Utilize purified recombinant protein for crystallography or cryo-EM

  • Identify binding pockets that could be targeted by small molecules

  • Design peptidomimetics based on functional domains

• Antibody Development:

  • Generate high-specificity antibodies against mpv17l2 for diagnostic purposes

  • Create blocking antibodies to study domain-specific functions

  • Develop immunotherapeutic approaches for conditions with mpv17l2 overexpression

• Screening Platforms:

  • Establish assays using recombinant mpv17l2 to screen for compounds that enhance its stability or function

  • Develop reporter systems to monitor mitochondrial translation in response to therapeutic candidates

  • Use Xenopus embryos expressing modified versions of mpv17l2 for in vivo screening

Recombinant mpv17l2 protein can be produced through various expression systems, with wheat germ cell-free systems showing particular promise for maintaining proper folding and functionality of this membrane protein .

What is the potential role of mpv17l2 in mitochondrial-targeted cancer therapies, particularly in the context of microRNA regulation?

Recent research has uncovered fascinating connections between mpv17l2 and cancer biology, particularly through microRNA regulation:

• miRNA Regulatory Mechanisms:

  • MPV17L2 has been identified as a direct target of miR-34a-5p

  • Bioengineered miR-34a-5p effectively reduces MPV17L2 protein levels

  • This leads to decreased respiratory chain Complex I activities and intracellular ATP

• Cancer Cell Metabolic Effects:

  • Modulation of MPV17L2 through miR-34a-5p reduces cancer cell mitochondrial respiration capacity

  • This is accompanied by increased oxidative stress and elevated apoptotic cell death

  • Higher levels of reactive oxygen species serve as indicators of cellular stress

• Therapeutic Development Strategies:

  • Design miRNA-based therapeutics targeting mpv17l2 in cancer cells

  • Develop combination approaches that exploit mitochondrial vulnerabilities

  • Use Xenopus models to test specificity and efficacy of these approaches

  • Engineer delivery systems to enhance tumor-specific targeting

• Research Methodology:

  • Employ dual luciferase reporter assays to validate direct targeting

  • Use Western blot analysis to confirm protein reduction

  • Apply Seahorse Mito Stress Test assays to measure functional impacts

  • Quantify ROS and apoptosis markers to assess cellular responses

These findings suggest the existence and importance of the miR-34a-5p-MPV17L2 pathway in controlling mitochondrial functions in human carcinoma cells, representing a potential therapeutic target that could be further validated using Xenopus models .